(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire Avidity Biosciences for $12 billion. Copyright 2025 Thomson Reuters.

(Reuters) -Swiss drugmaker Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for over $70 per share, ...

MOSCOW (Reuters) -Russian President Vladimir Putin's special envoy for investment and economic cooperation, Kirill Dmitriev, ...

WASHINGTON (Reuters) -U.S. Treasury Secretary Scott Bessent said on Sunday that he anticipates that China will revive ...

SEOUL (Reuters) -South Korea's HD Hyundai Heavy Industries and U.S. military shipbuilder Huntington Ingalls have agreed to ...

"The current chip crisis shows how fragile our world is. Unlike the last semiconductor crisis, this one involves very simple ...

HANOI/KUALA LUMPUR (Reuters) -The United States and Vietnam have agreed to a framework for an agreement on "reciprocal, fair ...

The CPI report was published despite an economic data blackout because of the government shutdown. The figure, used by the ...

(Reuters) -Target plans to lay off around 1,800 employees as part of its strategy to reverse stagnant sales, the Wall Street ...